From September 7th to 8th, Cao Sen, director of the Registrar of the Provincial Food and Drug Administration, and four people were invited to the site of the office to guide the construction of the biomedical industry project and the approval of pharmaceutical projects in Heze City. Zhang Kui, director of the Municipal Market Supervision Bureau, and Li Juan, director of the Sixth Branch of the Provincial Food and Drug Administration, accompanied the activities.
Cao Sen and his party inspected the production workshop and laboratory of Duomeikang Biological Company in Dingtao District, and put forward guidance on the issues of medical device project approval landing, warehousing management, cosmetics filing, approval cycle, etc., urging enterprises to be familiar with the priority approval policy, improve approval materials, and strive for early approval, early production, and early effectiveness. Organized a symposium on drug licensing and registration enterprises, and 15 pharmaceutical and mechanized production and wholesale enterprises, such as Buchang Pharmaceutical, CEFC Pharmaceutical, and Runze Pharmaceutical, each raised questions and confusions in product registration and administrative licensing. Cao Sen and other detailed answers guide enterprises on how to speed up the approval process and urge enterprises to apply for approval as soon as possible. Implement the "Framework Agreement on Cooperation between the Provincial Food and Drug Administration and the Municipal Government", support the development of Heze's biomedical industry, and effectively provide good services for enterprises. The Municipal Market Supervision Bureau will track and coordinate to promote the approval of the project as soon as possible.